People news

Agile Therapeutics, a specialty pharmaceutical company focused on women's healthcare products, has appointed Al Altomari as chairman of its board of directors.

August 14, 2008

7:16 pm

MANUFACTURERS

Agile Therapeutics, a specialty pharmaceutical company focused on women’s healthcare products, has appointed Al Altomari as chairman of its board of directors. Altomari currently serves as CEO of Barrier Therapeutics. Prior to Barrier, Altomari held several executive roles at Johnson & Johnson, and worked for Ortho-McNeil Pharmaceutical’s women’s health care franchise.

Introgen Therapeutics, a developer of molecular therapies for cancer, has appointed James Rothman, PhD, to the company’s board of directors. Rothman previously served as vice chairman of the Sloan-Kettering Research Institute of Memorial Sloan-Kettering cancer Center.

From Our Partners

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

Partner Content

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and streaming audio than in some of the more traditional ones.

A Big C Shift: Rebranding cancer to reflect advances in oncology

Partner Content

A Big C Shift: Rebranding cancer to reflect advances in oncology

Pivoting people’s perception of the disease to match the realities of treatment.